Arch Therapeutics, Inc. (OTCQB: ARTH), developer of the AC5 Surgical Hemostatic Device(TM), announced that it would be featured as a presenting company at the LD Micro conference on Thursday, December 4, 2014 at 12:00 PM EST.
http://bit.ly/11SjQTy
Tuesday, November 25, 2014
Arch Therapeutics to Present at LD Micro Main Event on December 4th 2014 | Publicwire
Arch Therapeutics, Inc. (OTCQB: ARTH), developer of the AC5 Surgical Hemostatic Device(TM), announced that it would be featured as a presenting company at the LD Micro conference on Thursday, December 4, 2014 at 12:00 PM EST.
http://bit.ly/11SjQTy
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment